Immunosuppressive Treatment for Inflammatory Cardiomyopathy: Meta-Analysis of Randomized Controlled Trials:Meta-Analysis of Randomized Controlled Trials
スポンサーリンク
概要
- 論文の詳細を見る
The use of immunosuppressive therapy for inflammatory cardiomyopathy is controversial. The aim of this review is to summarize the current empirical evidence for immunosuppressive treatment in inflammatory cardiomyopathy. We conducted a meta-analysis of all randomized controlled trials (RCTs) that compared immunosuppressive therapy with either placebo or conventional treatment in patients with inflammatory cardiomyopathy. The pooled outcomes were all-cause death and heart transplantation for inflammatory cardiomyopathy, left ventricular ejection fraction (LVEF), and left ventricular end diastolic dimension (LVEDD). Five trials involving 316 patients were included. Overall, immunosuppressive therapy was not superior to placebo and conventional therapy in the pooled outcome of all-cause death and heart transplantation (odds ratio [OR] 1.03, 95% confidence intervals [CI] 0.58 to 1.80) in the long-term. The pooled data showed that there might be a short-term beneficial effect on LVEF improvement (5.06%, 95% CI -0.07% to 10.18%) in patients receiving immunosuppressive therapy, but no beneficial effect on LVEDD either in the short-term (-0.87 mm; 95% CI, -8.29 to 6.55 in adult patients) or long-term (-0.52 mm, 95% CI -3.64 to 2.60 in adult patients) was observed. There is no evidence to suggest that immunosuppressive therapy has an effect on improving the survival of patients with inflammatory cardiomyopathy. Current therapy in inflammatory cardiomyopathy seems to be limited to supportive measures or transplantation.
- 一般社団法人 インターナショナル・ハート・ジャーナル刊行会の論文
一般社団法人 インターナショナル・ハート・ジャーナル刊行会 | 論文
- Influence of Renal Dysfunction on Clinical Outcomes in Patients With Congestive Heart Failure Complicating Acute Myocardial Infarction
- Three-Dimensional High-Density Bipolar Contact Mapping of Left Atrial Endocardial Activation During Sinus Rhythm in Patients With Atrial Fibrillation
- Rate-Dependent Electrophysiologic Effects of the Class III Antiarrhythmic Drugs Nifekalant, Amiodarone, and Ibutilide on the Atrium in Patients With Persistent Atrial Fibrillation
- Prediction of Coronary Artery Stenosis at Rest in Patients With Normal Left Ventricular Wall Motion:Segmental Analyses Using Strain Imaging Diastolic Index
- Subclinical Tonic-Clonic Epileptic Seizure Detected by an Implantable Loop Recorder